Life Science Editors published Chen et al. Predictive design of tissue-specific mammalian enhancers that function in the mouse embryo in Nat Genet (2026).
Public source
Publisher name
Public post
Just some of the super cool papers we helped with that were published last month. We love using our experience at the journals to help scientists sharpen their message a…
Company
Life Science Editors
Top level scientific communications support from a world-class team of former journal editors, writers and illustrators.
- Industry
- Writing and Editing
- Location
- Park City, US
- Company size
- 11–50 employees
About Life Science Editors
Our team of former-journal editors, grants specialists, writers, and illustrators collaborates with researchers, clinicians, institutions, and industry innovators to transform complex scientific ideas into compelling narratives. Why Partner With Us? Behind-the-Scenes Insight: We leverage our deep understanding of writing and publishing to provide the highest quality services. Tailored Support: Whether you’re refining a manuscript, crafting a grant proposal, or producing posters or slide decks our experts provide personalized feedback to sharpen your message and accelerate your success.
See moreLatest activity
Latest activity from Life Science Editors
10 signals
Research & Knowledge
Life Science Editors published a paper where Nautilus Biotechnology and partners applied Iterative Mapping to enable the capture of diverse proteoforms at the single-molecule level and applied it to Tau.
Research & Knowledge
Life Science Editors published a recent Snippet on a preprint selected by former Editor-in-Chief Stephen Matheson of Cell Reports.
Research & Knowledge
Life Science Editors published a new Snippet by Stephen Matheson exploring tools for harnessing connectomes and differences between male and female fly brains.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
asc Life Science
asc Life Science published research by Im, Jeong et al. in Nature Biotechnology, 2026, where they substituted TadA with an ADAR to reduce DNA off-targets to almost 0 and improve editing efficiency.
Research & Knowledge
Trilogy Writing & Consulting, An Indegene Company
Trilogy Writing & Consulting, An Indegene Company published an article exploring what ICH M11 means for medical writers and the future of protocol authoring.
Research & Knowledge
MDPI
MDPI published a selection of editor's choice articles published in the first half of 2026 in Biology MDPI
Research & Knowledge
Global Bio & Investment Monthly
Global Bio & Investment Monthly published a recent 2026 Science paper exploring the TAPIR platform and its implications for stem cell fate and regenerative medicine.
Research & Knowledge
Integrated DNA Technologies